top of page
CEDAR is a multi-centre, single arm, open label, retrospective and prospective enrolment, retrospective and prospective data collection, post-market registry study to assess the clinical outcomes of the Castor™ and Cratos™ Branched Aortic Stent Graft Systems in an all-comer, real world patient population.
Involving global investigational sites across EMEA with experience in Castor™ or Cratos™, and eligible patient enrolment at each, data on patients undergoing TEVAR with these devices will be collected in this large open-ended registry.
bottom of page